Literature DB >> 17445913

Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.

Katja Bauer1, Christina Schrader, Jochen Suess, Peter Wutzler, Michaela Schmidtke.   

Abstract

As an intermediate host of avian and human influenza A viruses (FLUAV) pigs may play a potential role in interspecies virus transmission and reassortment of viral genes including those conferring antiviral drug resistance. Porcine FLUAV isolated in Germany between 1989 and 2001 contains mutations in the M2 gene inducing amantadine resistance. No data exist on neuraminidase inhibitor (NAI) susceptibility of these porcine FLUAV. We studied the antiviral activity of NAI against seven selected H3N2 FLUAV isolated from pigs in Germany between 1982 and 1999. All isolates were susceptible towards oseltamivir and zanamivir in neuraminidase enzyme-inhibition assays. Both compounds inhibited virus spreading and reduced the virus yields and plaque size at low concentrations. Higher concentrations were necessary to reduce the plaque number. Two isolates that differed in glycosylation pattern of viral hemagglutinin (HA) showed markedly reduced drug susceptibility in cell culture-based assays.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445913     DOI: 10.1016/j.antiviral.2007.03.007

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

1.  Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.

Authors:  Katja Bauer; Ralf Dürrwald; Michael Schlegel; Kathrin Pfarr; Dominik Topf; Nadine Wiesener; Hans-Martin Dahse; Peter Wutzler; Michaela Schmidtke
Journal:  Med Microbiol Immunol       Date:  2011-06-19       Impact factor: 3.402

2.  Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.

Authors:  Tatiana Baranovich; Justin Bahl; Bindumadhav M Marathe; Marie Culhane; Evelyn Stigger-Rosser; Daniel Darnell; Bryan S Kaplan; James F Lowe; Richard J Webby; Elena A Govorkova
Journal:  Antiviral Res       Date:  2015-02-19       Impact factor: 5.970

Review 3.  Amantadine and rimantadine for influenza A in children and the elderly.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

4.  Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs.

Authors:  Ralf Duerrwald; Michael Schlegel; Katja Bauer; Théophile Vissiennon; Peter Wutzler; Michaela Schmidtke
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

5.  Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus.

Authors:  Elisabeth Walther; Zhongli Xu; Martina Richter; Johannes Kirchmair; Ulrike Grienke; Judith M Rollinger; Andi Krumbholz; Hans P Saluz; Wolfgang Pfister; Andreas Sauerbrei; Michaela Schmidtke
Journal:  Front Microbiol       Date:  2016-03-21       Impact factor: 5.640

6.  Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea.

Authors:  Han Sol Lee; Ji Yun Noh; Joon Young Song; Hee Jin Cheong; Won Suk Choi; Hye Won Jeong; Seong-Heon Wie; Woo Joo Kim
Journal:  Influenza Other Respir Viruses       Date:  2018-03-30       Impact factor: 4.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.